Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease.

Abstract

Gaucher disease (GD) is an autosomal recessive disorder caused by deficiency of β-glucocerebrosidase. Storage of glucosylceramide in reticuloendothelial cells results in multiorgan pathology including bone disease. Established skeletal disease may remain problematic despite Gaucher-specific treatment. Both osteopenia and osteonecrosis have been described but the underlying pathophysiology, in particular the role of monocyte-derived osteoclasts is not well defined. The objective of this study was to explore the effect of glucocerebrosidase deficiency, inhibition and replacement on osteoclast development and function. In cultures derived from GD patients, or where GBA was chemically inhibited multinucleate giant cells expressing markers of osteoclast differentiation occurred earlier and in greater numbers compared to normal controls and the functional capacity of osteoclasts for bone resorption was enhanced. Increases in osteoclast number and activity correlated with radiological markers of active bone disease. Abnormalities were reversed by addition of specific therapies and were attenuated by co-culture with cells derived from healthy controls (HCs). Numbers of osteoblast lineage cells in the peripheral blood were mismatched to osteoclast precursors indicating uncoupling of osteoblast-osteoclast regulation which may further impact on bone remodelling. Elucidation of the underlying mechanisms of these changes will suggest rational therapies for the most disabling aspect of this condition.

DOI: 10.1016/j.bcmd.2013.04.006
020406080201520162017
Citations per Year

Citation Velocity: 16

Averaging 16 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Reed2013EnhancedDO, title={Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease.}, author={Matt Reed and Robert J Baker and Atul B. Mehta and Derralynn Hughes}, journal={Blood cells, molecules & diseases}, year={2013}, volume={51 3}, pages={185-94} }